Hydrochloric Acid

Hydrochloric Acid

SCHEMBL10486017

C=Cc1ccccc1[P+](Cc1ccccc1)(c1ccccc1)c1ccccc1.[Cl-]

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
SNCA P37840 2/20 0.41
HIF1A Q16665 1/20 0.36
ALDH1A1 P00352 2/20 0.33
MAOB P27338 1/20 0.32
CYP1A2 P05177 2/20 0.32
EPHX1 P07099 1/20 0.31
CYP2D6 P10635 1/20 0.30
TSHR P16473 1/20 0.30
CYP2C19 P33261 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formic Acid SCHEMBL30601055 0.91 SNCA (0.37) SNCAHIF1AALDH1A1CYP1A2EPHX1
Sulfuric Acid SCHEMBL30240044 0.90 SNCA (0.36) SNCAHIF1ACYP1A2
Acetic Acid SCHEMBL28850582 0.87 SNCA (0.38) SNCAALDH1A1CYP1A2CYP2D6TSHR
Sulfurous Acid SCHEMBL28174995 0.87 SNCA (0.38) SNCAHIF1AALDH1A1CYP1A2CYP2D6
Sulfuric Acid SCHEMBL30070980 0.87 SNCA (0.38) SNCAALDH1A1CYP1A2CYP2D6TSHR
SCHEMBL2461053 0.81 CNR2 (0.38) ALDH1A1CYP1A2CYP2D6CYP2C19
Hydrochloric Acid SCHEMBL494 0.75 SNCA (0.63) SNCAHIF1AALDH1A1CYP1A2EPHX1
Hydrochloric Acid SCHEMBL7462753 0.74 SNCA (0.44) SNCAHIF1AALDH1A1MAOBCYP1A2
Hydrochloric Acid SCHEMBL10485992 0.74 HIF1A (0.40) SNCAHIF1AALDH1A1CYP1A2CYP2D6
Hydrochloric Acid SCHEMBL9850761 0.74 SNCA (0.44) SNCAHIF1AALDH1A1CYP1A2EPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3459975-B1 POLYMERIC ACID CATALYSTS AND USES THEREOF DSM NUTRITIONAL PRODUCTS LLC (US) 2024-10-02 EP claimed
CN-102585097-B Method for preparing amphoteric starch UNIV HENAN TECHNOLOGY 2013-06-12 CN claimed
CN-102585097-A Method for preparing amphoteric starch UNIV HENAN TECHNOLOGY 2012-07-18 CN claimed
EP-3166981-B1 OLIGOSACCHARIDE COMPOSITIONS AND METHODS FOR PRODUCING THEREOF DSM NUTRITIONAL PRODUCTS LLC (US) 2026-05-13 EP disclosed
US-12514267-B2 Oligosaccharide compositions for use as animal feed and methods of producing thereof DSM NUTRITIONAL PRODUCTS, LLC (US) 2026-01-06 US disclosed
US-12410206-B2 Oligosaccharide compositions and methods of use thereof for reducing ammonia levels DSM NUTRITIONAL PRODUCTS, LLC (US) 2025-09-09 US disclosed
US-20250057202-A1 OLIGOSACCHARIDE COMPOSITIONS FOR USE AS FOOD INGREDIENTS AND METHODS OF PRODUCING THEREOF DSM NUTRITIONAL PRODUCTS LLC (US) 2025-02-20 US disclosed
WO-2024203867-A1 HEAT-CURABLE RESIN, CURED OBJECT FORMED THEREFROM, AND HEAT-CURABLE COMPOSITION 第一工業製薬株式会社 2024-10-03 WO disclosed
WO-2024203866-A1 THERMOSETTING RESIN, CURED PRODUCT THEREOF, AND THERMOSETTING COMPOSITION 第一工業製薬株式会社 2024-10-03 WO disclosed
EP-3459975-B1 POLYMERIC ACID CATALYSTS AND USES THEREOF DSM NUTRITIONAL PRODUCTS LLC (US) 2024-10-02 EP disclosed
CN-113056488-B Oligosaccharide compositions and methods of use thereof for reducing ammonia levels DSM营养产品有限责任公司 2023-10-24 CN disclosed
CN-102585097-B Method for preparing amphoteric starch UNIV HENAN TECHNOLOGY 2013-06-12 CN disclosed
CN-102603976-B Preparation method of quaternary phosphonium cation starch microspheres UNIV HENAN TECHNOLOGY 2013-05-01 CN disclosed
CN-102603976-A Preparation method of quaternary phosphonium cation starch microspheres UNIV HENAN TECHNOLOGY 2012-07-25 CN disclosed
CN-102585097-A Method for preparing amphoteric starch UNIV HENAN TECHNOLOGY 2012-07-18 CN disclosed
US-4837392-A Dry electrostatographic developer containing toner particles comprising a vinyl addition polymer containing a covalently bound quaternary phosphonium salt EASTMAN KODAK COMPANY (US) 1989-06-06 US disclosed
US-4837391-A HEAT RESISTANCE, COMPATAIBILITY EASTMAN KODAK COMPANY (US) 1989-06-06 US disclosed
EP-0096647-B1 A METHOD FOR PREPARING A POLYMER CONTAINING PENDANT UNSATURATION THE GOODYEAR TIRE & RUBBER COMPANY (US) 1986-10-29 EP disclosed
US-4446284-A Method for preparing a polymer containing pendant unsaturation THE GOODYEAR TIRE & RUBBER COMPANY (US) 1984-05-01 US disclosed
EP-0096647-A2 A method for preparing a polymer containing pendant unsaturation THE GOODYEAR TIRE & RUBBER COMPANY (US) 1983-12-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12410206-B2 Oligosaccharide compositions and methods of use thereof for reducing ammonia levels OAT, OTC, FUCA2 SNCA 4339/4885HIF1A 654/4885ALDH1A1 1582/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.